Press Releases
November 2, 2023
Panbela Announces Publication of Preclinical and Clinical Data: Inhibition of Polyamine Biosynthesis Preserves β Cell Function in Type 1 Diabetes
A Phase 1 clinical study showed that DFMO treatment may provide metabolic benefits to preserve β cell function and health in T1D.
October 31, 2023
Panbela Announces Validation of European Patent for Claims of a Novel Process for the Production of SBP-101
October 25, 2023
Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication
October 24, 2023
Panbela to Host Third Quarter 2023 Earnings Conference Call on 11/9/23
September 26, 2023
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101
September 19, 2023
Panbela to Present at the LD Micro Investor Conference
September 5, 2023
Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of Flynpovi
August 28, 2023
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
August 14, 2023
Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101
August 10, 2023
Panbela Provides Business Update and Reports Q2 2023 Financial Results
Events & Presentations